Minnesota health care, led by insurer Bright Health, has driven the venture-capital investments and headlines for the last two years.
In fact, in 2019, Bright Health pulled in $635 million alone, on top of $200 million in 2018, according to PitchBook, which tracks private investments and other financial metrics.
The Big 10 Minnesota venture-capital (VC) recipients last year, led by Bright Health, pulled in $929 million, a record, including $79 million for Nuvaira and $17.2 million for No. 10 Spineology.
Those 10 companies alone raised more than the previous record, 2018, when fledgling Minnesota companies raised $786 million in venture capital, according to PitchBook.
Bright Health has raised more than $1 billion since its founding in 2015.
Med-tech companies in Minnesota, the traditional VC sweet spot for 40-plus years, has raised at least $356 million in private funding in 2019, led by Nuvaira. The Plymouth-based med-tech company, which announced a $79 million equity financing round in February, is engaged in key tests of its lung denervation therapy for COPD and asthma.
Previously, Medical Alley Association calculated that nearly 100 early-stage Minnesota health care companies in insurance, med-tech, health data and biotech raised at least $1.12 billion in 2019, representing an increase of more than 60% over 2018's total.
It also was a banner year nationally.